Rapid Therapeutic Science Laboratories, Inc. (RTSL)

RTSL Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2019	2017	2016	2015	2014	2013	2012
Net Income	-1.69	-4.2	-0.35	-2.55	-0.02	-0.01	-0.01	-0.02	-
Depreciation & Amortization	0.02	0.06	0.04	0.02	0	0	0	0	0
Share-Based Compensation	0.02	0.02	0.04	0.01	0	0	0	0	0
Other Operating Activities	0.5	1.91	0.16	2.4	-0	0	0	0.01	-
Operating Cash Flow	-1.15	-2.21	-0.11	-0.13	-0.02	-0.01	-0.01	-0.01	-0.02
Capital Expenditures	-0.04	-0.29	-0.16	-0.04	0	0	0	0	0
Investing Cash Flow	-0.04	-0.29	-0.16	-0.04	0	0	0	0	0
Common Stock Issued	0	0.59	0.08	0	0	0	0	0	0
Other Financing Activities	1	1.61	0.02	0.17	0.02	0.01	-	-	-
Financing Cash Flow	1	2.2	0.1	0.17	0.02	0.01	0	0	0.05
Net Cash Flow	-0.19	-0.31	-0.01	0	-0	-0	-0.01	-0.01	0.03
Free Cash Flow	-1.19	-2.5	-0.26	-0.17	-0.02	-0.01	-0.01	-0.01	-0.02
Free Cash Flow Margin	-	-468476.03%	-2863.97%	-	-	-	-	-	-
Free Cash Flow Per Share	-0.15	-0.33	-5.43	-1.71	-0.20	-0.10	-0.08	-0.12	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.